Omnivision Group (603501.SH) Passes HKEX Hearing, Ranks as World's Third-Largest Digital Image Sensor Supplier

Stock News12-15

Omnivision Integrated Circuits (Group) Co., Ltd. (603501.SH) has passed the Hong Kong Stock Exchange (HKEX) main board listing hearing, with UBS, CICC, PASCHK, and GFSHK serving as joint sponsors.

The company is a global Fabless semiconductor design firm, with CMOS image sensors (CIS) as its flagship product. Known for its proprietary technology, diversified product portfolio, flexible Fabless model, and extensive client and supply chain network, Omnivision operates across three core business lines: image sensor solutions, display solutions, and analog solutions. It continues to expand its offerings to serve high-growth sectors such as smartphones, automotive, healthcare, security, and emerging markets (machine vision, smart glasses, and edge AI).

Backed by a robust intellectual property portfolio and collaborative manufacturing platforms with leading global suppliers, Omnivision has built an award-winning suite of core technologies. In smartphone CIS, it launched the OV50X sensor in April 2025, featuring LOFIC technology for single-exposure HDR under any lighting condition. For automotive applications, its TheiaCel®-enabled OX08D10 (8MP), OX05D10 (5MP), OX12A10 (12MP), and OX03H10 (3MP) sensors meet next-gen ADAS and autonomous driving requirements.

In medical imaging, Omnivision introduced the OCH2B30 module in June 2024 for 3D dental scanners. The company also established a machine vision division in 2024 and released the OP03050 and OG0TC BSI global shutter sensors in July 2024 as part of its edge AI initiative.

Per Frost & Sullivan data, Omnivision ranks among the top three Fabless IC design companies globally by 2024 revenue, with comprehensive capabilities to develop mission-critical semiconductor solutions. Notably, it holds a 13.7% market share as the world’s third-largest digital image sensor supplier by 2024 revenue.

Financially, Omnivision reported revenues of approximately RMB 20.04 billion (2022), RMB 20.98 billion (2023), RMB 25.71 billion (2024), and RMB 13.94 billion (Jan–Jun 2025), with net profits of RMB 951 million, RMB 544 million, RMB 3.28 billion, and RMB 2.02 billion for the respective periods.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment